Brief: FDA Approves Acetadote® SNDA
09/12/2024 21:22
Dec 9 (Reuters) - Cumberland Pharmaceuticals Inc
CPIX.O :
* FDA APPROVES ACETADOTE® SNDA
Source text: ID:nPn6HWkmJa
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM